Recommendations for the treatment of lipid disorders in patients on peritoneal dialysis. ISPD guidelines/recommendations. International Society for Peritoneal Dialysis.
Fried
L
L
University of Pittsburgh School of Medicine, Pennsylvania, USA.
Hutchison
A
A
Stegmayr
B
B
Prichard
S
S
Bargman
J M
JM
D001053:Apolipoproteins / Q000097:blood; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007674:Kidney Diseases / Q000150:complications; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D010530:Peritoneal Dialysis; D011322:Primary Prevention; D012307:Risk Factors
D001053:Apolipoproteins; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D008055:Lipids; D008074:Lipoproteins